CytomX Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2013 | $888.0K | $-15.0M | $-15.1M |
| FY2014 | $5.1M | $-29.8M | $-30.3M |
| FY2015 | $7.7M | $-33.2M | $-35.4M |
| FY2016 | $15.0M | $-59.6M | $-58.9M |
| FY2017 | $71.6M | $-46.3M | $-43.1M |
| FY2018 | $59.5M | $-77.9M | $-84.6M |
| FY2019 | $26.9M | $-141.5M | $-132.8M |
| FY2020 | $68.4M | $-80.5M | $-64.8M |
| FY2021 | $37.3M | $-116.0M | $-115.9M |
| FY2022 | $53.2M | $-101.3M | $-99.3M |
| FY2023 | $101.2M | $-6.5M | $-569.0K |
| FY2024 | $138.1M | $25.0M | $31.9M |
| FY2025 | $76.2M | $-22.4M | $-17.4M |